# OnCo record paul-baas (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/paul-baas/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "paul-baas" ;
  schema:name "Paul Baas"@en ;
  schema:description "Led CheckMate 743, the trial that gave mesothelioma its first new first-line therapy in 16 years."@en ;
  schema:url <https://onco.cc/people/paul-baas/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/?term=Baas%20P%5BAuthor%5D%20mesothelioma%20nivolumab> ;
  onco:tag "mesothelioma", "immunotherapy" ;
  schema:jobTitle "Thoracic Oncologist, Netherlands Cancer Institute; Professor, University of Amsterdam" ;
  schema:sameAs <https://orcid.org/0000-0001-7018-9556> ;
  onco:cancers <https://onco.cc/cancers/mesothelioma/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/> ;
  onco:targets <https://onco.cc/targets/pd1/>, <https://onco.cc/targets/ctla4/> ;
  onco:drugs <https://onco.cc/drugs/nivolumab/>, <https://onco.cc/drugs/ipilimumab/> ;
  onco:institutions <https://onco.cc/institutions/nki/> ;
  onco:trials <https://onco.cc/trials/checkmate-743/> ;
  schema:affiliation <https://onco.cc/institutions/nki/> .